Sanovas Competitors and Similar CompaniesClear all
Sanovas's competitors and similar companies include Pulmonx, Lung Therapeutics, Glaukos and Medacta International.
 Sanovas Sanovas offers micro-invasive devices and drug delivery technologies for the treatment of lung and pulmonary diseases. |  Pulmonx Pulmonx is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema. |  Lung Therapeutics Lung Therapeutics is a biopharmaceutical company developing medicines for unmet medical needs in fibrosis and lung disease. |  Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. |  Medacta International Medacta (also known as Medacta International) is a company that develops and manufactures medical devices for orthopedic and spine surgery. | |
Founding Date | Founding Date 2009 | Founding Date 1998 | Founding Date 2013 | Founding Date 1998 | Founding Date 1999 |
Type | Type Private | Type Public | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Petaluma, US HQ San Rafael, US | Locations Redwood City, US HQ Neuchâtel, CH | Locations Austin, US HQ | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more | Locations Castel San Pietro, CH HQ Lane Cove West, AU Straß In Steiermark, AT Nivelles, BE Kitchener, CA Nanterre, FR Göppingen, DE see more |
Employees | Employees 15 | Employees 2209% increase | Employees 10 | Employees 90716% increase | Employees 809 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 265.1 m | Valuation ($) N/A | Valuation ($) 7.6 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $90.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $507.4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $23.4m (FY, 2025) | Cost of goods N/A | Cost of goods $111.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $67.1m (FY, 2025) | Gross profit N/A | Gross profit $282.8m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($54m) (FY, 2025) | Net income N/A | Net income ($187.7m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 285.7k (over 10 years ago) | Latest funding round N/A | Latest funding round $ 36m (about 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 6.7m | Total funding raised $ 257.4m | Total funding raised $ 53.9m | Total funding raised $ 115m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Pulmonx
HQ
Redwood City, US
Employees
220↑ 9% increase
Pulmonx is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema.
View companyLung Therapeutics
HQ
Austin, US
Employees
10
Lung Therapeutics is a biopharmaceutical company developing medicines for unmet medical needs in fibrosis and lung disease.
View companyGlaukos
HQ
Aliso Viejo, US
Employees
907↑ 16% increase
Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases.
View companyMedacta International
HQ
Castel San Pietro, CH
Medacta (also known as Medacta International) is a company that develops and manufactures medical devices for orthopedic and spine surgery.
View company